nakijiquinone C

RN given for (1R-(1alpha,2beta,4abeta,8aalpha))-isomer; a Her-2/Neu receptor antagonist; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 11/28/2001 - "Investigation of the kinase-inhibiting properties of the synthesized derivatives revealed that the C-2 epimer 30 of nakijiquinone C is a potent and selective inhibitor of the KDR receptor, a receptor tyrosine kinase involved in tumor angiogenesis. "

1.	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
2.	Phosphotransferases (Kinase)